Showing results (21-30 of 52) with videos related to

Sort By:
Pageof 6
Scientific Reports|August 16, 2017
Targeting Apolipoprotein E/Amyloid β Binding by Peptoid CPO_Aβ17-21 P Ameliorates Alzheimer's Disease Related Pathology and Cognitive DeclineShan Liu, Shinae Park, Grant Allington, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 29, 2012
Low-density lipoprotein receptor overexpression enhances the rate of brain-to-blood Aβ clearance in a mouse model of β-amyloidosisJoseph M Castellano, Rashid Deane, Andrew J Gottesdiener, et al.
Diagnostics (Basel, Switzerland)|August 29, 2024
PrecivityAD2™ Blood Test: Analytical Validation of an LC-MS/MS Assay for Quantifying Plasma Phospho-tau217 and Non-Phospho-tau217 Peptide Concentrations That Are Used with Plasma Amyloid-β42/40 in a Multianalyte Assay with Algorithmic Analysis for Detecting Brain Amyloid PathologyStephanie M Eastwood, Matthew R Meyer, Kristopher M Kirmess, et al.
Molecular Neurodegeneration|April 23, 2013
In vivo measurement of apolipoprotein E from the brain interstitial fluid using microdialysisJason D Ulrich, Jack M Burchett, Jessica L Restivo, et al.
Journal of Personalized Medicine|October 28, 2025
Implementation of an Alzheimer's Disease Blood Test: Adoption Experience by Memory Care Specialists in a Multi-Center StudyMark Monane, Robert M Carlile, Kim G Johnson, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 17, 2026
Plasma p-tau217 predicts PET-based pathological staging for precision Alzheimer disease assessmentHan-Kyeol Kim, Jae Hoon Lee, Joong-Hyun Chun, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|August 27, 2025
Racial and ethnic differences in plasma p-tau217 ratio biomarker eligibility rates in a preclinical AD trial with lecanemabDoris P Molina-Henry, Rema Raman, Andy Liu, et al.
JAMA|July 28, 2024
Blood Biomarkers to Detect Alzheimer Disease in Primary Care and Secondary CareSebastian Palmqvist, Pontus Tideman, Niklas Mattsson-Carlgren, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|May 20, 2021
The PrecivityAD™ test: Accurate and reliable LC-MS/MS assays for quantifying plasma amyloid beta 40 and 42 and apolipoprotein E proteotype for the assessment of brain amyloidosisKristopher M Kirmess, Matthew R Meyer, Mary S Holubasch, et al.
Toxicology and Applied Pharmacology|March 19, 2017
The effect of angiotensin receptor neprilysin inhibitor, sacubitril/valsartan, on central nervous system amyloid-β concentrations and clearance in the cynomolgus monkeyHeidi A Schoenfeld, Tim West, Philip B Verghese, et al.
Pageof 6